Fermenta Biotech Ltd.
Fermenta Biotech Ltd. Fundamental Analysis
Fermenta Biotech Ltd. (FERMENTA.BO) shows strong financial fundamentals with a PE ratio of 11.17, profit margin of 16.15%, and ROE of 25.12%. The company generates $5.5B in annual revenue with strong year-over-year growth of 40.79%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 76.8/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze FERMENTA.BO's fundamental strength across five key dimensions:
Efficiency Score
ExcellentFERMENTA.BO demonstrates superior asset utilization.
Valuation Score
ExcellentFERMENTA.BO trades at attractive valuation levels.
Growth Score
ModerateFERMENTA.BO shows steady but slowing expansion.
Financial Health Score
ExcellentFERMENTA.BO maintains a strong and stable balance sheet.
Profitability Score
ModerateFERMENTA.BO maintains healthy but balanced margins.
Key Financial Metrics
Is FERMENTA.BO Expensive or Cheap?
P/E Ratio
FERMENTA.BO trades at 11.17 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, FERMENTA.BO's PEG of -0.52 indicates potential undervaluation.
Price to Book
The market values Fermenta Biotech Ltd. at 2.51 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 6.68 times EBITDA. This is generally considered low.
How Well Does FERMENTA.BO Make Money?
Net Profit Margin
For every $100 in sales, Fermenta Biotech Ltd. keeps $16.15 as profit after all expenses.
Operating Margin
Core operations generate 17.35 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $25.12 in profit for every $100 of shareholder equity.
ROA
Fermenta Biotech Ltd. generates $13.48 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Fermenta Biotech Ltd. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Fermenta Biotech Ltd. generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
FERMENTA.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
11.17
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.52
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.51
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.83
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.29
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.50
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.25
vs 25 benchmark
ROA
Return on assets percentage
0.13
vs 25 benchmark
ROCE
Return on capital employed
0.22
vs 25 benchmark
How FERMENTA.BO Stacks Against Its Sector Peers
| Metric | FERMENTA.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 11.17 | 28.45 | Better (Cheaper) |
| ROE | 25.12% | 763.00% | Weak |
| Net Margin | 16.15% | -45265.00% (disorted) | Strong |
| Debt/Equity | 0.29 | 0.34 | Neutral |
| Current Ratio | 1.50 | 2795.60 | Neutral |
| ROA | 13.48% | -16588.00% (disorted) | Strong |
FERMENTA.BO outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Fermenta Biotech Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
63.30%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
28.26%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
119.55%
Industry Style: Defensive, Growth, Innovation
High Growth